KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Resmed (RMD) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Resmed (RMD) over the last 17 years, with Q4 2025 value amounting to $11.8 million.

  • Resmed's Other Operating Expenses rose 649.04% to $11.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $46.5 million, marking a year-over-year increase of 362.0%. This contributed to the annual value of $20.2 million for FY2023, which is N/A changed from last year.
  • Resmed's Other Operating Expenses amounted to $11.8 million in Q4 2025, which was up 649.04% from $12.0 million recorded in Q3 2025.
  • In the past 5 years, Resmed's Other Operating Expenses registered a high of $21.5 million during Q2 2023, and its lowest value of $7.4 million during Q1 2021.
  • Moreover, its 5-year median value for Other Operating Expenses was $11.1 million (2024), whereas its average is $10.6 million.
  • Its Other Operating Expenses has fluctuated over the past 5 years, first surged by 17324.27% in 2023, then crashed by 4760.89% in 2024.
  • Quarter analysis of 5 years shows Resmed's Other Operating Expenses stood at $7.7 million in 2021, then rose by 23.58% to $9.6 million in 2022, then increased by 21.06% to $11.6 million in 2023, then dropped by 4.58% to $11.0 million in 2024, then rose by 6.49% to $11.8 million in 2025.
  • Its Other Operating Expenses stands at $11.8 million for Q4 2025, versus $12.0 million for Q3 2025 and $11.9 million for Q2 2025.